| Literature DB >> 27247072 |
Oliver T Zishiri1, Nelisiwe Mkhize, Samson Mukaratirwa.
Abstract
Salmonellosis is a significant public health concern around the world. The injudicious use of antimicrobial agents in poultry production for treatment, growth promotion and prophylaxis has resulted in the emergence of drug resistant strains of Salmonella. The current study was conducted to investigate the prevalence of virulence and antimicrobial resistance genes from Salmonella isolated from South African and Brazilian broiler chickens as well as human clinical isolates. Out of a total of 200 chicken samples that were collected from South Africa 102 (51%) tested positive for Salmonella using the InvA gene. Of the overall 146 Salmonella positive samples that were screened for the iroB gene most of them were confirmed to be Salmonella enterica with the following prevalence rates: 85% of human clinical samples, 68.6% of South African chicken isolates and 70.8% of Brazilian chicken samples. All Salmonella isolates obtained were subjected to antimicrobial susceptibility testing with 10 antibiotics. Salmonella isolates from South African chickens exhibited resistance to almost all antimicrobial agents used, such as tetracycline (93%), trimethoprim-sulfamthoxazole (84%), trimethoprim (78.4%), kanamycin (74%), gentamicin (48%), ampicillin (47%), amoxicillin (31%), chloramphenicol (31%), erythromycin (18%) and streptomycin (12%). All samples were further subjected to PCR in order to screen some common antimicrobial and virulence genes of interest namely spiC, pipD, misL, orfL, pse-1, tet A, tet B, ant (3")-la, sul 1 and sul. All Salmonella positive isolates exhibited resistance to at least one antimicrobial agent; however, antimicrobial resistance patterns demonstrated that multiple drug resistance was prevalent. The findings provide evidence that broiler chickens are colonised by pathogenic Salmonella harbouring antimicrobial resistance genes. Therefore, it is evident that there is a need for prudent use of antimicrobial agents in poultry production systems in order to mitigate the proliferation of multiple drug resistance across species.Entities:
Keywords: Salmonella; antimicrobial resistance; chicken; human; susceptibility; virulence gene.
Mesh:
Substances:
Year: 2016 PMID: 27247072 PMCID: PMC6238664 DOI: 10.4102/ojvr.v83i1.1067
Source DB: PubMed Journal: Onderstepoort J Vet Res ISSN: 0030-2465 Impact factor: 1.792
Primers used to confirm Salmonella spp.
| Target gene | Primer sequence (5’→ 3’) | Product size (bp) | Reference |
|---|---|---|---|
| F:TCATCGCACCGTCAAAGGAACC | 284 | Li | |
| F:TGC GTA TTC TGT TTG TCG GTCC | 606 | Baumler |
Note: Please see the full reference list of the article, Zishiri, O.T., Mkhize, N. & Mukaratirwa, S., 2016, ‘Prevalence of virulence and antimicrobial resistance genes in Salmonella spp. isolated from commercial chickens and human clinical isolates from South Africa and Brazil’, Onderstepoort Journal of Veterinary Research 83(1), a1067. http://dx.doi.org/10.4102/ojvr.v83i1.1067, for more information.
used to confirm all Salmonella spp.
used to confirm Salmonella enterica.
Primers used to detect virulence genes in Salmonella spp.
| Target gene | Primer sequence (5’ → 3’) | Size (bp) | Annealing temperature | Mechanism of resistance | Broad action |
|---|---|---|---|---|---|
| F:CCTGGATAATGACTATTGAT | 309 | 54 | Type III secretion system | Survival in macrophages | |
| F:GTCGGCGAATGCCGCGAATA | 400 | 60 | Involved in intramacrophage survival | Survival in macrophages | |
| F:GGAGTATCGATAAAGATGTT | 550 | 60 | Adhesin/autotransporter | Colonisation | |
| F:CGGCGATTCATGACTTTGAT | 350 | 56 | Type III secretion effector associated with SPI-1 system | Enteritis |
Source: Hughes, L.A., Shopland, S., Wigley, P., Bradon, H., Leatherbarrow, A.H., Williams, N.J. et al., 2008, ‘Characterisation of Salmonella enterica serotype Typhimurium isolates from wild birds in northern England from 2005–2006’, Journal of Infectious Disease in Developing Countries 4, 4. http://dx.doi.org/10.1186/1746-6148-4-4
Primers used to screen antimicrobial resistance genes in Salmonella spp.
| Antimicrobial agent | Target gene | Primer sequence (5’–3’) | Size (bp) | References | Mechanism of resistance |
|---|---|---|---|---|---|
| Ampicillin | F:CGCTTCCCGTTAACAAGTAC | 419 | Bacci | - | |
| Gentamicin | F:GTGGATGGCGGCCTGAAGCC | 526 | Bacci | Aminoglycoside adenyltransferase | |
| Tetracycline | F:GCTACATCCTGCTTGCCTTC | 210 | Bacci | Efflux | |
| F:TTGGTTAGGGGCAAGTTTTG | 659 | Bacci | Efflux | ||
| Sulfamethoxazole | F:GCG CGG CGT GGG CTA CCT | 350 | Poppe | Dihydropteroate synthase inhibitor | |
| F:CGG CAT CGT CAA CAT AACC | 720 | Poppe | Dihydropteroate synthase inhibitor |
FIGURE 1Detection of the 284 bp invA gene amplicon from eight representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 2Detection of the 606 bp iroB gene amplicon from nine representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 3Detection of the 309 bp spiC gene amplicon from eight representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 4Detection of the 550 bp misL gene amplicon from seven representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 5Detection of the 350 bp orfL gene amplicon from nine representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 6Detection of the 400 bp pipD gene amplicon from nine representative Salmonella isolates by agarose gel electrophoresis.
Prevalence of virulence genes in Salmonella isolates from three different origins.
| Origin | Virulence genes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of isolates ( | % | % | % | % | % | % | |||||||
| SABC | 102 | 102 | 100 | 48 | 47 | 36 | 35 | 2 | 2 | 21 | 20.6 | 70 | 68.6 |
| BBC | 24 | 24 | 100 | 20 | 83 | 21 | 87.5 | 7 | 29 | 6 | 25 | 17 | 70.8 |
| SAHC | 20 | 20 | 100 | 17 | 85 | 16 | 80 | 15 | 75 | 10 | 20 | 17 | 85 |
| Total | 146 | 146 | 100 | 85 | 58 | 73 | 50 | 24 | 16 | 37 | 25 | 104 | 71.2 |
SABC, South African broiler chicken isolates; BBC, Brazilian broiler chicken isolates; SAHC, South African human clinical isolates.
Antimicrobial susceptibility tests on Salmonella isolates of different origins.
| Antibiotics | Number of isolates | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SABC | BBC | SAHC | ||||||||||||||||
| R | % | I | % | S | % | R | % | I | % | S | % | R | % | I | % | S | % | |
| AMP | 48 | 47.0 | 41 | 40.0 | 13 | 13.0 | 24 | 100.0 | 0 | 0.0 | 0 | 0.0 | 3 | 15 | 8 | 40 | 9 | 45 |
| AML | 32 | 31.0 | 45 | 44.0 | 25 | 25.0 | 20 | 83.0 | 3 | 12.5 | 1 | 4.2 | 6 | 30 | 5 | 25 | 9 | 45 |
| C | 32 | 31.0 | 30 | 29.0 | 40 | 39.0 | 1 | 4.2 | 2 | 8.3 | 21 | 88.0 | 0 | 0 | 1 | 5 | 19 | 95 |
| CN | 49 | 48.0 | 26 | 26.0 | 27 | 26.5 | 3 | 12.5 | 3 | 12.5 | 18 | 75.0 | 0 | 0 | 0 | 0 | 20 | 100 |
| E | 18 | 18.0 | 13 | 13.0 | 71 | 69.6 | 15 | 62.5 | 6 | 25.0 | 3 | 12.5 | 6 | 30 | 10 | 50 | 4 | 20 |
| K | 75 | 74.0 | 9 | 9.0 | 18 | 18.0 | 4 | 16.7 | 0 | 0.0 | 20 | 83.0 | 1 | 5 | 0 | 0 | 19 | 95 |
| S | 12 | 12.0 | 8 | 8.0 | 82 | 80.0 | 3 | 12.5 | 15 | 62.5 | 6 | 25.0 | 4 | 20 | 3 | 15 | 13 | 65 |
| SXT | 86 | 84.3 | 0 | 0.0 | 16 | 15.7 | 12 | 50.0 | 4 | 16.7 | 8 | 33.0 | 3 | 15 | 0 | 0 | 17 | 85 |
| TE | 95 | 93.0 | 7 | 7.0 | 0 | 0.0 | 20 | 83.0 | 0 | 0.0 | 4 | 16.7 | 2 | 10 | 1 | 50 | 17 | 85 |
| W | 80 | 78.4 | 4 | 3.9 | 19 | 18.6 | 16 | 66.7 | 3 | 12.5 | 5 | 20.8 | 4 | 20 | 2 | 10 | 14 | 70 |
AMP, ampicillin; AML, amoxicillin; C, chloramphenicol; CN, gentamicin; E, erythromycin; K, kanamycin; S, streptomycin; STX, trimethoprim-sulfamthoxazole; TE, tetracycline; W, trimethoprim; SABC, South African broiler chicken isolates; BBC, Brazilian broiler chicken isolates; SAHC, South African human clinical isolates; R, Resistant; I, Intermediate susceptibility; S, Susceptible.
n = 102;
n = 24;
n = 20.
Antibiotic resistance patterns of Salmonella isolates illustrating multiple drug resistance.
| Antibiotic resistance patterns | Number of isolates | |||||
|---|---|---|---|---|---|---|
| SABC | % | BBC | % | SAHC | % | |
| AMP, TE | 32 | 31.4 | 20 | 83.0 | 1 | 5 |
| AML, TE | 31 | 30.4 | 16 | 66.7 | 2 | 10 |
| TE, W | 74 | 72.5 | 14 | 58.0 | 1 | 5 |
| S, TE | 12 | 11.8 | 3 | 12.5 | 0 | 0 |
| K, TE | 71 | 69.6 | 3 | 12.5 | 0 | 0 |
| SXT, TE | 69 | 67.6 | 10 | 41.7 | 0 | 0 |
| E, TE | 14 | 13.7 | 12 | 50.0 | 2 | 10 |
| C, TE | 19 | 18.6 | 1 | 4.2 | 0 | 0 |
| AMP, AML, TE | 30 | 25.0 | 16 | 80.0 | 1 | 5 |
| AMP, C, TE | 10 | 9.8 | 1 | 4.2 | 0 | 0 |
| E, W | 18 | 17.6 | 12 | 50.0 | 4 | 20 |
| E, SXT, W | 15 | 14.7 | 9 | 37.5 | 1 | 5 |
| S, SXT, W | 11 | 10.8 | 3 | 12.5 | 0 | 0 |
| TE, W | 74 | 72.4 | 14 | 58.0 | 1 | 5 |
| AML, AMP, TE, W | 23 | 22.5 | 12 | 50.0 | 0 | 0 |
| AML, AMP, E, TE | 12 | 11.8 | 10 | 41.7 | 0 | 0 |
AMP, ampicillin; AML, amoxicillin; C, chloramphenicol; CN, gentamicin; E, erythromycin; K, kanamycin; S, streptomycin; STX, trimethoprim-sulfamthoxazole; TE, tetracycline; W, trimethoprim; SABC, South African broiler chicken isolates; BBC, Brazilian broiler chicken isolates; SAHC, South African human clinical isolates.
FIGURE 7Detection of the 412 bp pse-1 gene amplicon from eight representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 8Detection of the 526 bp ant (3”)-la gene amplicon from eight representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 9Detection of the 210 bp tet A gene amplicon from seven representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 10Detection of the 659 bp tet B gene amplicon from four representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 11Detection of the 350 bp sul 1 gene amplicon from seven representative Salmonella isolates by agarose gel electrophoresis.
FIGURE 12Detection of the 720 bp sul 2 gene amplicon from eight representative Salmonella isolates by agarose gel electrophoresis.
Prevalence of antimicrobial resistance genes screened from 146 Salmonella isolates.
| Antibiotics | Resistance genes | Number of isolates | |||||
|---|---|---|---|---|---|---|---|
| SABC | % | BBC | % | SAHC | % | ||
| Ampicillin | 57 | 56.0 | 15 | 63 | 10 | 50 | |
| Gentamicin | 33 | 32.0 | 18 | 75 | 16 | 80 | |
| Sulfamethoxazole | 44 | 43.0 | 20 | 83 | 12 | 60 | |
| 43 | 42.0 | 19 | 79 | 12 | 60 | ||
| 18 | 17.6 | 18 | 75 | 10 | 50 | ||
| Tetracycline | 45 | 44.0 | 20 | 83 | 14 | 70 | |
| 29 | 28.0 | 8 | 33 | 12 | 60 | ||
| 15 | 14.7 | 6 | 25 | 7 | 35 | ||
n = 102;
n = 24;
n = 20.